Login Register Cart 0
Generic placeholder image

Anti-Infective Agents

Editor-in-Chief

ISSN (Print): 2211-3525
ISSN (Online): 2211-3533

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Postpartum Posterior Reversible Encephalopathy Syndrome in a Patient Suspected to COVID-19

Author(s): Fatemeh Ramezanpour, Ashraf Zarvani and Athena Sharifi-Razavi*

Volume 19, Issue 3, 2021

Published on: 17 November, 2020

Page: [341 - 344] Pages: 4

DOI: 10.2174/2211352518999201117093045

Price: $65

Abstract

The effect of a novel beta coronavirus named SARS-CoV-2 or COVID-19 on pregnancy outcomes and the neonatal prognosis is not fully documented yet.

Case Presentation: In this article, we describe a patient presented with frequent seizure and blurred vision 6 days after delivery without symptoms and laboratory data in favor of preeclampsia/eclampsia and evaluations consistent with Posterior Reversible Encephalopathy Syndrome. Also, there was mild clinical and radiological evidence of COVID-19 infection.

Conclusion: In conclusion, as pregnancy is a high-risk state, pregnant women may be more vulnerable to severe COVID-19 infection and also pregnancy complications.

Keywords: Betacoronavirus, radiological evidence, COVID-19 infection, encephalopathy, maternal-fetal transmission, levetiracetam.

Graphical Abstract

[1]
David, A. Schwartz. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch. Pathol. Lab. Med., 2020, 144(7), 799-805.
[http://dx.doi.org/10.5858/arpa.2020-0901-SA]
[2]
Rasmussen, S.A.; Smulian, J.C.; Lednicky, J.A.; Wen, T.S.; Jamieson, D.J. Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know. Am. J. Obstet. Gynecol., 2020, 222(5), 415-426.
[3]
ACOG practice bulletinno. 202: gestational hypertension and preeclampsia. Obstet. Gynecol., 2019, 133, e1-e25.
[4]
Levine, R.J.; Lam, C.; Qian, C.; Yu, K.F.; Maynard, S.E.; Sachs, B.P.; Sibai, B.M.; Epstein, F.H.; Romero, R.; Thadhani, R.; Karumanchi, S.A. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med., 2006, 355(10), 992-1005.
[http://dx.doi.org/10.1056/NEJMoa055352] [PMID: 16957146]
[5]
Sargent, I.L.; Germain, S.J.; Sacks, G.P.; Kumar, S.; Redman, C.W. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J. Reprod. Immunol., 2003, 59(2), 153-160.
[http://dx.doi.org/10.1016/S0165-0378(03)00044-5] [PMID: 12896819]
[6]
Hosapatna, B.D.; Saha, P.K.; Bagga, R.; Khandelwal, N.; Modi, M. Neuroradiological perspectives of severe preeclampsia and eclampsia spectrum-correlation from posterior reversible encephalopathy syndrome. Pregnancy Hypertens., 2020, 20, 119-123.
[http://dx.doi.org/10.1016/j.preghy.2020.04.003] [PMID: 32283331]
[7]
Papoutsis, D.; El-Attabi, N.; Sizer, A. Postpartum posterior reversible encephalopathy syndrome (PRES) in a twin pregnancy complicated by preeclampsia-eclampsia: case report. Clin. Exp. Obstet. Gynecol., 2014, 41(3), 351-353.
[PMID: 24992794]
[8]
Lio, Chon-Fu Posterior reversible encephalopathy syndrome in a postpartum hemorrhagic woman without hypertension: a case report. Medicine, 2017, 96, 16.
[http://dx.doi.org/10.1097/MD.0000000000006690]
[9]
Li, Y.C.; Bai, W.Z.; Hashikawa, T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol., 2020, 92(6), 552-555.
[http://dx.doi.org/10.1002/jmv.25728] [PMID: 32104915]
[10]
Sharifi-Razavi, A.; Sedaghat, Z.; Baziboroun, M.; Karimi, N. COVID-19 accompanied with intracerebral hemorrhage: a case series. Arch. Clin. Infect. Dis., 2020, 15(4), e104877.
[http://dx.doi.org/10.5812/archcid.104877]
[11]
M. Mardani1, S. Alireza Nadji2, K. Aghazadeh Sarhangipor3, A. Sharifi-Razavi4 and M. Baziboroun1. COVID-19 infection recurrence presenting with meningoencephalitis. New Microbes New Infect., 2020, 37, 100732.
[http://dx.doi.org/10.1016/j.nmni.2020.100732]
[12]
Anand, P. Posterior reversible encephalopathy syndrome in patients with coronavirus disease 2019: two cases and a review of the literature. J. Stroke Cerebrovasc. Dis., 2020, 10, 5212.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105212]
[13]
D’Amore, F.; Vinacci, G.; Agosti, E.; Cariddi, L.P.; Terrana, A.V.; Vizzari, F.A.; Mauri, M.; Giorgianni, A. Pressing issues in COVID-19: probable cause to seize SARS-CoV-2 for its preferential involvement of posterior circulation manifesting as severe posterior reversible encephalopathy syndrome and posterior strokes. AJNR Am. J. Neuroradiol., 2020, 41(10), 1800-1803.
[http://dx.doi.org/10.3174/ajnr.A6679] [PMID: 32732268]
[14]
Chen, D. Recurrence of positive SARS-COV-2 RNA in COVID-19: a case report. Int. J. Inf. Dis., 2020, 93, 297-299.
[15]
WHO. Available from: https://www.who.int/internal-publications-detail/clinical-management

Rights & Permissions Print Cite
Article Metrics
12
1
© 2024 Bentham Science Publishers | Privacy Policy